ACTO Achieves Veeva Gold Product Partner Status After Nearly a Decade of Collaboration

ACTO Achieves Gold Status as Veeva Product Partner

Date: September 3, 2026
Location: Toronto and New York

In a remarkable achievement, ACTO has been awarded the Gold Product Partner status by Veeva, following a decade-long partnership dedicated to optimizing the performance of client teams in the life sciences sector. This honor highlights ACTO's commitment to merging human intelligence with empathetic AI, enhancing field team efficiency, compliance, and overall client engagement within the pharmaceutical and biotechnology industries.

ACTO's innovative approach has been exemplified by their AI-powered platform, which focuses on excellence in field operations, allowing teams to access approved content and real-time information. The awarded status places ACTO among the elite circle of Veeva's Gold Product Partners, showcasing their dedication to excellence through integrated solutions tailored for life science professionals.

The partnership between ACTO and Veeva began in 2017, and through continuous collaboration, ACTO achieved Silver Partner status in 2021 before becoming an AI partner in 2024. This progressive journey reflects their unwavering commitment to their clients, aiming to support life science companies in accelerating their training, enhancing field execution, and ensuring compliance during customer engagements.

Parth Khanna, CEO of ACTO, stated, “At every product launch and scientific update, field teams must keep pace with the latest approved information. Our long-standing partnership with Veeva has allowed us to closely integrate ACTO with the systems our clients use daily. The attainment of Gold Product Partner status reinforces our mutual commitment to assisting life science companies in improving their readiness and operational execution at scale.”

The validated integrations with Veeva applications empower life science field teams to train, coach, and execute workflows efficiently, leveraging reliable enterprise content and data to boost performance. ACTO’s simulated training solution, CxZone, enables field representatives to practice healthcare professional interactions using approved messaging and promotional content from Veeva PromoMats while being able to handle scientific discussions using medical content from Veeva MedComms—all seamlessly facilitated within Veeva Vault CRM.

Additionally, ACTO Talk TRx™ provides easy access to current and approved content stored in Veeva PromoMats and MedComms, complete with key discussion points and best practice advice for utilizing these resources in healthcare interactions.

Kristn Peck, Vice President of Alliances at Veeva, shared, “ACTO has been a valuable product partner since 2017. Achieving Gold Product Partner status reflects ACTO’s ongoing commitment to delivering integrated and Veeva-validated solutions for the life sciences sector. We congratulate ACTO on this success.”

To explore how ACTO and Veeva are working together to enhance field team readiness, operational efficiency, and client engagement, you can visit their booth at the Fierce PharmaWeek in Philadelphia from September 14 to 17. For more information, visit www.acto.com, and follow ACTO on LinkedIn for the latest updates.

About ACTO

ACTO serves 14 of the 50 largest pharmaceutical companies and leading biotech firms, redefining how therapies reach patients post-regulatory approval. By uniting human intelligence with empathetic AI, ACTO empowers field excellence, accelerates product launches, and deepens customer engagement. Their AI-driven platform and SuperAgents AI enhance training and coaching, freeing teams to focus on critical relationships, sound judgment, and strategic execution. ACTO is compliant with the stringent regulatory standards of the industry, validated against FDA 21 CFR Part 11 and certified SOC 2 Type II. For further details, visit www.acto.com.